Northern Netherlands Region grant for Prof. Quax
Prof. Wim Quax from the Groningen Research Institute of Pharmacy (GRIP) has received a grant worth EUR 200,000 from the Northern Netherlands Region (Samenwerkingsverband Noord-Nederland). Prof. Quax receives this grant for his project ‘Citrus bioflavonoid hesperidin as anti-viral agent for SARS-CoV-2’. With this project, he aims to investigate a possible treatment of corona with hesperidin.
This flavonoid has been suggested to block the connection between the SARS-CoV-2 virus and the ACE2 receptor of human cells. The group of Prof. Quax will analyze how hesperidin reduces the affinity of the spike protein for its target, the ACE2 receptor. Hesperidin is a cheap by-product of citrus fruits and has been used safely in humans for years. Together with project partner Color&Brain, alternative delivery routes and their effects on virus binding will be investigated.
| Last modified: | 01 July 2020 1.31 p.m. |
More news
-
23 September 2025
Reduced working hours for a smaller carbon footprint?
Klaus Hubacek analyses the effects of various green solutions to reduce CO2 emissions — such as planting more trees, sharing cars, or working less — to find out whether they realize their intended outcome. Spoiler: almost everything has a downside,...
-
23 September 2025
ASML takes a share in Mistral – why does a hardware company need AI?
Recently, ASML acquired an 11 percent share in Mistral AI, a French company. Ming Cao, Professor of Networks and Robotics at the University of Groningen, explains why a chip-machine factory requires AI.
-
16 September 2025
The ocean absorbs carbon from the air, but what if the temperature increases?
‘Fortunately, seawater absorbs carbon dioxide (CO₂). If it didn’t, things would have been over and done with already,’ according to climate and ocean researchers Richard Bintanja and Rob Middag. But what actually happens to the ocean's carbon...